TEAMManagement Team

Moa Fransson

Moa Fransson

CEO, PhD
Holds a PhD in gene and immunotherapy and a vast experience in coaching startup companies and entrepreneurs from Uppsala University and in Europe within EITHealth. Previous experience from pre-clinical development in bladder cancer gene therapy and CAR-T cell treatments, co-founder of a startup for medical devices and receiver of several awards in the field of pre-clinical research and commercialization.
Cecilia Drakskog

Cecilia Drakskog

Head of preclinical dev.
Immunologist and infection biologist with experience in assay development and clinical study design from Stockholm University and Karolinska Institute. Cecilia has a broad background in management of pre-clinical programs.
Katrin Klocke

Katrin Klocke

Senior scientist, PhD
Holds a PhD in immunology and autoimmunity from Karolinska Institute and has a vast experience investigating complex protein structures and signaling pathways within immunology and cell biology. Katrin has previous experience from larger pharmaceutical companies evaluating clinical therapeutical candidates and documented expertise within advanced flow cytometry validation techniques.

TEAMBoard of Directors

Anders Nordström

Anders Nordström

Chairman of the Board
Executive positions in life science companies and executive Vice President and Board Member in global life science companies.
Richard Åhlberg

Richard Åhlberg

Senior physician Karolinska University Hospital, MD, PhD
Former medical director and business director at Roche and Aleris. Boardmember in several biotech and healthcare companies.
Karin von Wachenfeldt

Karin von Wachenfeldt

PhD
CEO of Truly Labs and over twenty-five years experience of drug discovery in different environments ranging from small biotech to Big Pharma.
Johan Lund

Johan Lund

PhD
CEO of KyNexis and Chairman of the Board of Aqilion. Over 20 years in pharmaceutical industry leading Research and early development within Celgene, Pfizer and AstraZeneca.
Svein Mathisen

Svein Mathisen

M.Sc. in Engineering Physics
More than 25 years of experience in various senior positions in the Norsk Hydro Group and as CEO of BioInvent International AB. Boardmember in several healthcare companies.
Andries Blokzijl

Andries Blokzijl

Founder of Genagon and scientific advisor, MD, PhD
Licensed physician and researcher in signal transduction. Highly cited publications.
Simon Fredriksson

Simon Fredriksson

Experienced life science entrepreneur, PhD
Co-founder and former CSO and CEO of Olink AB. Previously Board member of Olink, Biolamina. Presently Board member of Cartana and Olink Proteomics.